{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T11:25:28Z","timestamp":1763810728966},"reference-count":55,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p><jats:italic>Cutibacterium acnes<\/jats:italic> has been associated with chronic prostatitis, which can potentially favor the appearance of tumors in the prostate. Prostatitis is difficult to treat, and the drug needs to be able to penetrate the prostate. The aim was to investigate the pharmacokinetics of clindamycin in the interstitial fluid of rat prostate using microdialysis. Microdialysis probes were recovered <jats:italic>in\u2009vitro<\/jats:italic> and <jats:italic>in\u2009vivo<\/jats:italic>. Clindamycin was administered at 80\u2009mg\/kg <jats:italic>iv bolus<\/jats:italic> for plasma and tissue pharmacokinetic experiments. A microdialysis probe was implanted in the prostate gland for collections over an 8\u2010hour period. The pharmacokinetic parameters were determined by both compartmental and non\u2010compartmental approaches. Penetration was determined as the ratio between the area under the curve and the time of the clindamycin measurement in the prostate. The recovery of the <jats:italic>in\u2009vivo<\/jats:italic> probes was 38.11\u2009\u00b1\u20091.14%. The plasma profile was modeled by a two\u2010compartment pharmacokinetic model. Clindamycin presented a prostate\/plasma ratio of 1.02, with free concentrations above the minimum inhibitory concentration for <jats:italic>Cutibacterium acnes<\/jats:italic> isolates. This was the first study that determined clindamycin free concentrations in the prostatic fluid of rats. These findings suggest that clindamycin may be an effective alternative for the treatment of prostatitis caused by <jats:italic>Cutibacterium acnes<\/jats:italic>.<\/jats:p>","DOI":"10.1111\/apm.13205","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T17:20:45Z","timestamp":1641230445000},"page":"197-205","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Is clindamycin a potential treatment for prostatitis?"],"prefix":"10.1111","volume":"130","author":[{"given":"Lisiani","family":"Ritter","sequence":"first","affiliation":[{"name":"College of Pharmacy University of Caxias do Sul Caxias do Sul Rio Grande do Sul Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa","family":"Bergoza","sequence":"additional","affiliation":[{"name":"College of Pharmacy University of Caxias do Sul Caxias do Sul Rio Grande do Sul Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduarda","family":"Possa","sequence":"additional","affiliation":[{"name":"College of Pharmacy University of Caxias do Sul Caxias do Sul Rio Grande do Sul Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro","family":"Tasso","sequence":"additional","affiliation":[{"name":"College of Pharmacy University of Caxias do Sul Caxias do Sul Rio Grande do Sul Brazil"},{"name":"Laboratory of Pharmacokinetics Health Sciences Postgraduate Program and Biotechnology Postgraduate Program University of Caxias do Sul Caxias do Sul Rio Grande do Sul Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055380"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00003-13"},{"issue":"4","key":"e_1_2_6_4_1","first-page":"262","article-title":"Role of Propionibacterium acnes in sarcoidosis: a meta\u2010analysis","volume":"30","author":"Zhou Y","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/935289"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.31145"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e31818e28dc"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12306-012-0183-6"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/804391"},{"issue":"6","key":"e_1_2_6_10_1","first-page":"241","article-title":"Propionibacterium acnes biofilm endocarditis requiring radical cardiac debridement and prosthetic valve replacements","volume":"44","author":"Beliaev AM","year":"2014","journal-title":"ANZ J Surg"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-105"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2012.10.017"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2014.02.004"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000158161.15277.78"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-006-0054-2"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2090"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2010.08.014"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2017.167"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01543-07"},{"key":"e_1_2_6_20_1","article-title":"Plasma concentration of Propionibacterium acnes antibodies and prostate cancer risk: results from an Australian population\u2010based case\u2013control study","volume":"411","author":"Severi G","year":"2010","journal-title":"Br J Cancer"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2012.02905.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090324"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22648"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31192"},{"key":"e_1_2_6_25_1","first-page":"11","article-title":"Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer","volume":"9","author":"Davidsson S","year":"2016","journal-title":"Inf Ag Cancer"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00463-13"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12178-014-9256-5"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1997.tb01094.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.887"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04292.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000074526"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1972.tb00052.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01652-1"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4977"},{"key":"e_1_2_6_35_1","volume-title":"Bioanalytical Method Validation. Guidance for Industry. US Department of Health and Human Services, Food and Drug Administration","author":"US Food and Drug Administration","year":"2018"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2006.11.019"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-017-0108-2"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-9929-8"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(83)80012-2"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.1.123"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1159\/000238501"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.9.1433"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/22.Supplement_D.199"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/28.4.547"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01710740"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.6.993"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2046-2051.2000"},{"issue":"8","key":"e_1_2_6_48_1","first-page":"548","article-title":"Comparison of ofloxacin and norfloxacin concentration in prostatic tissues in patients undergoing transurethral resection of the prostate","volume":"100","author":"Chen J","year":"2001","journal-title":"J. Formos. Med. Assoc"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2001.13.1.82"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.2165\/0044011-200929010-00003"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.08.005"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1159\/000329520"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.06.011"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.3552"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03752.x"},{"key":"e_1_2_6_56_1","unstructured":"The European Committee on Antimicrobial Susceptibility Testing \u2013 EUCAST. Accessed October 9 2020.https:\/\/www.eucast.org"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apm.13205","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/apm.13205","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apm.13205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T05:51:29Z","timestamp":1693115489000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apm.13205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1111\/apm.13205"],"URL":"https:\/\/doi.org\/10.1111\/apm.13205","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"assertion":[{"value":"2021-07-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}